IL2 and infectious disease: In the present study we prospectively evaluated the performances of in-house IFN-γ and IL-2 based ELISPOT assays by the use of a panel of Mycobacterium tuberculosis antigens in children consecutively referred to one paediatric infectious disease unit and at risk for TB infection with the aim of investigating possible immunological markers for a differential diagnosis between LTBI and active TB.